BEAMBeam Therapeutics Inc.

$30.17

What is the market doing?

What the tape says about BEAM

Beam Therapeutics Inc. is +69% over the past year while the S&P 500 is +23%: 46 points ahead of the market.

+69%

1-year return · S&P 500 +23%

vs 200-day average
+8.5%

vs 200-day average · close to trend

RSI (14)
62

RSI (14) · neutral

Below its 52-week high
−15%

Below its 52-week high

2024-08-06$14.54 – $35.53 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$30.17
1 monthS&P 500 +3.7%
+17%
1 yearS&P 500 +23%
+69%
5 yearsS&P 500 +87%
−67%
vs 50-day average$29.25
+3.1%
52-week high
$35.53
52-week low
$16.01
Annualised volatility
74%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$10M
Calendar-year price return
YearReturn
2026 (year to date)+8.8%
2025+12%
2024−8.9%
2023−30%
2022−51%
2021−2.4%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan63 of 6+1.6%
Feb64 of 6+11%
Mar70 of 7−20%
Apr74 of 7−7.1%
May74 of 7+7.6%
Jun76 of 7+13%
Jul73 of 7+4.0%
Aug73 of 7−0.81%
Sep62 of 6+1.3%
Oct63 of 6+2.3%
Nov65 of 6+17%
Dec63 of 6+7.6%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.